![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page0142.png)
142
SCIENTIFIC PROGRAMME
| Programme and Exhibition Guide
MONDAY 8 MAY 2017
15:45 > Standard treatment in anal cancer: where do we stand and where should
we go?
Speaker: R. Muirhead (UK)
SP-0471
JOINT SYMPOSIUM
ESTRO-RANZCR: Big data to better radiotherapy
14:45 - 16:15 | STOLZ 1-2
This session covers the topic of Big Data to Better Radiotherapy from the standpoints
of data collection and interpretation, types of datasets (genetic, dosimetric, clinical),
application of big datasets in the settings of planning and radiotherapy delivery, and
the potential clinical gains in cancer patient care arising from these.
Highlights of the international expert panel talks include:
• How big data compliments/differs from traditional clinical trial research
• The challenges and processed in big data collection
• New opportunities in the field of radiogenomics
• Big data in improving plan quality and automation
• Translating what we learn from big data to the clinical setting and individual
patient care
Chair: J. Alsner (Denmark)
Chair: S. Turner (Australia)
14:45 > The pros, cons, process and challenges for achieving better radiotherapy
through data -an introduction
Speaker: L.C. Holloway (Australia)
SP-0472
15:07 > From genomics and radiogenomics data to a better RT
Speaker: A. Vega (Spain)
SP-0473
15:29 > From radiotherapy and dosimetry data to better plans
Speaker: M. Hoogeman (The Netherlands)
SP-0474
15:51 > Moving big data into clinical practice – a positive outlook
Speaker: S. Vinod (Australia)
SP-0475
SYMPOSIUM
Locally advanced breast cancer
14:45 - 16:15 | SCHUBERT
Patients with breast cancer showing unfavourable prognostic factors, either
related to tumour extent or molecular subtype, use to have a multimodality